Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
ELC Group
ELC Group
Activities:
Regulatory
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery
The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
ISPE announces 2024 Facility of the Year Awards category winners
The awards programme recognises pharmaceutical companies that are the 'best' in the industry for innovation, operations, digitalisation, supply chain and social impact
Tabletability, compactability and compressibility: What’s the difference?
To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Research & Development
ELC Group in early stage development of novel influenza vaccine
€1m project marks regulatory affairs provider’s entry into the pharmaceutical development market
ELC Group expands into pharmaceutical product development market
Regulatory affairs provider creating extensive product portfolio for sale across US, EU, Latin America, Middle East and North Africa and China
Regulatory
ELC Group signs €1.5m regulatory affairs contract with Chinese pharma company
Endorses its Concept to Commercialisation approach to regulatory affairs consultancy services
Regulatory
ELC Group expands corporate presence in Czech Republic
Major contract wins in China and US fuel latest move into larger premises in Prague
Regulatory
ELC Group appoints Head of Regulatory Affairs for Russia and CIS
Inna Demidova to head new Moscow office for global regulatory affairs specialist
Regulatory
Regulatory review and outlook for 2013 and beyond
<b>28 February - 1 March 2013</b><br> <i>Two-day seminar</i><br> Mumbai, India
Regulatory
ELC Group expands its offices in Ahmedabad, India
Regulatory affairs specialist continues its growth in the country
Subscribe now